These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24887335)

  • 81. Weight gain in children on oxcarbazepine monotherapy.
    Garoufi A; Vartzelis G; Tsentidis C; Attilakos A; Koemtzidou E; Kossiva L; Katsarou E; Soldatou A
    Epilepsy Res; 2016 May; 122():110-3. PubMed ID: 27010568
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Characteristics and indications of oxcarbazepine].
    Herranz JL; Argumosa A
    Rev Neurol; 2002 Sep; 35 Suppl 1():S101-9. PubMed ID: 12373662
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant.
    Hooper WD; Dickinson RG; Dunstan PR; Pendlebury SC; Eadie MJ
    Clin Exp Neurol; 1987; 24():105-12. PubMed ID: 3268334
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Population pharmacokinetic modeling and simulation of huperzine A in elderly Chinese subjects.
    Sheng L; Qu Y; Yan J; Liu GY; Wang WL; Wang YJ; Wang HY; Zhang MQ; Lu C; Liu Y; Jia JY; Hu CY; Li XN; Yu C; Xu HR
    Acta Pharmacol Sin; 2016 Jul; 37(7):994-1001. PubMed ID: 27180987
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Population pharmacokinetics modeling of levetiracetam in Chinese children with epilepsy.
    Wang YH; Wang L; Lu W; Shang DW; Wei MJ; Wu Y
    Acta Pharmacol Sin; 2012 Jun; 33(6):845-51. PubMed ID: 22669118
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Population pharmacokinetics of carbamazepine in elderly patients.
    Punyawudho B; Ramsay ER; Brundage RC; Macias FM; Collins JF; Birnbaum AK
    Ther Drug Monit; 2012 Apr; 34(2):176-81. PubMed ID: 22406657
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Oxcarbazepine in the treatment of epilepsy].
    Freidel M; Krause E; Kuhn K; Peper R; Vogel H
    Fortschr Neurol Psychiatr; 2007 Feb; 75(2):100-6. PubMed ID: 17200915
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine.
    Theis JG; Sidhu J; Palmer J; Job S; Bullman J; Ascher J
    Neuropsychopharmacology; 2005 Dec; 30(12):2269-74. PubMed ID: 16052246
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparison of oxcarbazepine and carbamazepine: a double-blind study.
    Reinikainen KJ; Keränen T; Halonen T; Komulainen H; Riekkinen PJ
    Epilepsy Res; 1987 Sep; 1(5):284-9. PubMed ID: 3504404
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial.
    French JA; Baroldi P; Brittain ST; Johnson JK;
    Acta Neurol Scand; 2014 Mar; 129(3):143-53. PubMed ID: 24359313
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.
    Lin CM; Fan HC; Chao TY; Chu DM; Lai CC; Wang CC; Chen SJ
    BMC Pediatr; 2016 May; 16():61. PubMed ID: 27142370
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment.
    Friis ML; Kristensen O; Boas J; Dalby M; Deth SH; Gram L; Mikkelsen M; Pedersen B; Sabers A; Worm-Petersen J
    Acta Neurol Scand; 1993 Mar; 87(3):224-7. PubMed ID: 8475694
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparative stereoselective pharmacokinetic analysis of 10-hydroxycarbazepine after oral administration of its individual enantiomers and the racemic mixture to dogs.
    Volosov A; Yagen B; Bialer M
    Epilepsia; 2000 Sep; 41(9):1107-11. PubMed ID: 10999549
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Therapeutic drug monitoring of oxcarbazepine].
    Bouquié R; Dailly E; Bentué-Ferrer D;
    Therapie; 2010; 65(1):61-5. PubMed ID: 20205998
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
    Berghuis B; van der Palen J; de Haan GJ; Lindhout D; Koeleman BPC; Sander JW;
    Epilepsia; 2017 Jul; 58(7):1227-1233. PubMed ID: 28542738
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Oxcarbazepine.
    Beydoun A; Kutluay E
    Expert Opin Pharmacother; 2002 Jan; 3(1):59-71. PubMed ID: 11772334
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Open prospective study on oxcarbazepine in epilepsy in children: a preliminary report.
    Franzoni E; Garone C; Sarajlija J; Gualandi S; Malaspina E; Cecconi I; Moscano FC; Marchiani V
    Seizure; 2006 Jul; 15(5):292-8. PubMed ID: 16554175
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Oxcarbazepine in the treatment of early childhood epilepsy.
    Gaily E; Granström ML; Liukkonen E
    J Child Neurol; 1997 Nov; 12(8):496-8. PubMed ID: 9430314
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Severe overdosage with the antiepileptic drug oxcarbazepine.
    van Opstal JM; Janknegt R; Cilissen J; L'Ortije WH; Nel JE; De Heer F
    Br J Clin Pharmacol; 2004 Sep; 58(3):329-31. PubMed ID: 15327594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.